5.40Open5.40Pre Close0 Volume0 Open Interest22.50Strike Price0.00Turnover125.76%IV-14.84%PremiumAug 16, 2024Expiry Date7.61Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8645Delta0.0468Gamma1.90Leverage Ratio-0.0191Theta-0.0097Rho-1.64Eff Leverage0.0084Vega
Quanterix Stock Discussion
ABOS PEPG TOPS AAPL DIS XPEV MNMD TSM QTRX
$Acumen Pharmaceuticals(ABOS.US)$ $PepGen(PEPG.US)$ $Top Ships(TOPS.US)$ $Apple(AAPL.US)$ $Disney(DIS.US)$ $XPeng(XPEV.US)$ $Mind Medicine(MNMD.US)$ $Taiwan Semiconductor(TSM.US)$ $Quanterix(QTRX.US)$
In reaction to earnings/guidance:
• $GoodRx(GDRX.US)$ +38.5%, $EDGIO(EGIO.US)$ +13.5%, $Lemonade(LMND.US)$ +10.7%, $Desktop Metal(DM.US)$ +8.5%, $ShockWave Medical(SWAV.US)$ +8.2%, $Pubmatic(PUBM.US)$ +8.1%, $Olaplex(OLPX.US)$ +7%, $Vivid Seats(SEAT.US)$ +6.4%, $Noble(NE.US)$ +6.3%, $Aspen Technology(AZPN.US)$ +5.4%, $AAON Inc(AAON.US)$ +5%, $Hudbay Minerals(HBM.US)$ +5%, $Vivint Smart Home(VVNT.US)$ +4.9%, $Vivint Smart Home(VVNT.US)$ +4...
• $MillerKnoll(MLKN.US)$ +12.4%, $BioNTech(BNTX.US)$ +7.4%, $Lululemon Athletica(LULU.US)$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics(ADGI.US)$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
No comment yet